A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome

Levamisole has been considered the least toxic and least expensive steroid-sparing drug for preventing relapses of steroid-sensitive idiopathic nephrotic syndrome (SSINS). However, evidence for this is limited as previous randomized clinical trials were found to have methodological limitations. Ther...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Gruppen, Mariken P, Bouts, Antonia H, Jansen-van der Weide, Marijke C, Merkus, Maruschka P, Zurowska, Aleksandra, Maternik, Michal, Massella, Laura, Emma, Francesco, Niaudet, Patrick, Cornelissen, Elisabeth AM, Schurmans, Thierry, Raes, Ann, Vande Walle, Johan, van Dyck, Mieke, Gulati, Ashima, Bagga, Arvind, Davin, Jean-Claude
Format:	Artikel
Sprache:	eng
Schlagworte:	CHILDHOOD children EFFICACY levamisole Medicine and Health Sciences nephrotic syndrome randomized clinical trial steroid sensitive SUBGROUP ANALYSIS
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!